Phenotypic and molecular characterization of hyperpigmented group B Streptococci.


Autoria(s): Lupo, Agnese; Ruppen, Corinne; Hemphill, Andrew; Spellerberg, Barbara; Sendi, Parham
Data(s)

16/05/2014

Resumo

Group B Streptococcus (GBS) causes invasive infections in neonates, older adults and patients with comorbidities. β-hemolysin/cytolysin is an important GBS virulence factor. It is encoded by the cyl operon and confers GBS hemolytic activity. Isolates displaying hyperpigmentation are typically hyperhemolytic. Comparison of clonally identical isolates displaying different levels of pigmentation has shown transcriptional dysregulation due to mutations in components of the control of the virulence S/R (CovS/R) regulatory system. In addition, hyperpigmented isolates show decreased CAMP factor and decreased capsule thickness. In analogy to findings in group A Streptococcus, a pivotal role of CovS/R has been proposed in the host-pathogen interaction of invasive GBS infection. However, corresponding investigations on multiple clinical GBS isolates have not been performed. We prospectively collected hyperpigmented isolates found in a diagnostic laboratory and performed phenotypic, molecular and transcriptional analyses. In the period from 2008 to 2012, we found 10 isolates obtained from 10 patients. The isolates reflected both invasive pathogens and colonizers. In three cases, clonally identical but phenotypically different variants were also found. Hence, the analyses included 13 isolates. No capsular serotype was found to be significantly more frequent. Bacterial pigments were analyzed via spectrophotometry and for their hemolytic activity. Data obtained for typical absorbance spectra peaks correlated significantly with hemolytic activity. Molecular analysis of the cyl operon showed that it was conserved in all isolates. The covR sequence displayed mutations in five isolates; in one isolate, the CovR binding site to cylX was abrogated. Our results on clinical isolates support previous findings on CovR-deficient isogenic mutants, but suggest that - at least in some clinical isolates - for β-hemolysin/cytolysin and CAMP factor production, other molecular pathways may be involved.

Formato

application/pdf

Identificador

http://boris.unibe.ch/53859/1/1-s2.0-S143842211400054X-main.pdf

Lupo, Agnese; Ruppen, Corinne; Hemphill, Andrew; Spellerberg, Barbara; Sendi, Parham (2014). Phenotypic and molecular characterization of hyperpigmented group B Streptococci. International journal of medical microbiology IJMM, 304(5-6), pp. 717-724. Elsevier 10.1016/j.ijmm.2014.05.003 <http://dx.doi.org/10.1016/j.ijmm.2014.05.003>

doi:10.7892/boris.53859

info:doi:10.1016/j.ijmm.2014.05.003

info:pmid:24933304

urn:issn:1438-4221

Idioma(s)

eng

Publicador

Elsevier

Relação

http://boris.unibe.ch/53859/

Direitos

info:eu-repo/semantics/restrictedAccess

Fonte

Lupo, Agnese; Ruppen, Corinne; Hemphill, Andrew; Spellerberg, Barbara; Sendi, Parham (2014). Phenotypic and molecular characterization of hyperpigmented group B Streptococci. International journal of medical microbiology IJMM, 304(5-6), pp. 717-724. Elsevier 10.1016/j.ijmm.2014.05.003 <http://dx.doi.org/10.1016/j.ijmm.2014.05.003>

Palavras-Chave #570 Life sciences; biology #610 Medicine & health
Tipo

info:eu-repo/semantics/article

info:eu-repo/semantics/publishedVersion

PeerReviewed